Acute flaccid paralysis

Anna Julia Lacerda Raposo; Eduardo Galvão Freire; Célia Raiany Ferreira de Farias; e Pinheiro Renato Serquiz; Francisco Irochima Pinheiro; Fausto Pierdoná Guzen; Amália Cinhtia Meneses Rêgo; Irami Araújo-Filho

doi:10.30574/gscbps.2019.9.1.0197

Authors

Anna Julia Lacerda Raposo Undergraduate Student of Medicine at UnP - Potiguar University - Laureate International Universities – Natal/Brazil.
Eduardo Galvão Freire Undergraduate Student of Medicine at UnP - Potiguar University - Laureate International Universities – Natal/Brazil.
Célia Raiany Ferreira de Farias Undergraduate Student of Medicine at UnP - Potiguar University - Laureate International Universities – Natal/Brazil.
e Pinheiro Renato Serquiz Neurologist and Professor at Potiguar University / UnP - Laureate International Universities – Natal/Brazil.
Francisco Irochima Pinheiro Postgraduate Program in Biotechnology at Potiguar University/ UnP - Laureate International Universities – Natal/Brazil. Ph.D. in Health Science.
Fausto Pierdoná Guzen Postgraduate Program in Biotechnology at Potiguar University/ UnP - Laureate International Universities – Natal/Brazil. Ph.D. in Health Science.
Amália Cinhtia Meneses Rêgo Postgraduate Program in Biotechnology at Potiguar University/ UnP - Laureate International Universities – Natal/Brazil. Ph.D. in Health Science.
Irami Araújo-Filho Postgraduate Program in Biotechnology at Potiguar University/ UnP - Laureate International Universities – Natal/Brazil. Ph.D. in Health Science.

DOI:

https://doi.org/10.30574/gscbps.2019.9.1.0197

Keywords:

Paralysis, Acute inflammatory polyneuropathy, Acute autoimunne neuropathies, Acute infectious polyneuritis, Acute transverse myelitis, Myasthenic syndromes

Abstract

Acute Flaccid Paralysis (AFP) is a syndrome characterized by a diffuse, acute muscular weakness that develops with hypotonia and deep or abolished hypoactive reflexes. Literature review of the last five years in the databases Pubmed, Scopus, Embase, and Web of Science. Data were collected from epidemiological studies using the keywords. AFP includes heterogeneous diseases, variable clinical presentation, and correlated with a specific etiology. The differential diagnosis of acute flaccid paralysis includes spinal cord diseases, acute polyneuropathies, myoneural plaque dysfunction, and muscle disease. PFAs represents a set of disorders used by the World Health Organization (WHO) as an indicator of polio eradication. Therefore, the knowledge and understanding of the respective etiologies are necessary to make their differential diagnosis and appropriate treatment.

Metrics

Metrics Loading ...

References

Statland JM, Fontaine B, Hanna MG, Johnson NE, Kissel JT, Sansone VA and Griggs RC. (2018). Review of the diagnosis and treatment of periodic paralysis. Muscle & nerve, 57(4), 522-530.

Little AA and Albers JW. (2015). Clinical description of toxic neuropathies. Handb Clin Neurol, 131(3), 253-96.

Fatemi Y and Chakraborty R. (2019). Acute Flaccid Myelitis: A Clinical Overview for 2019. Mayo Clin Proc, 94(5), 875-881.

Bowley MP and Chad AD. (2019). Clinical neurophysiology of demyelinating polyneuropathy. Handb Clin Neurol, 161(3), 241-268.

Suresh S, Forgie S and Robinson J. (2018). Non‐polio Enterovirus detection with acute flaccid paralysis: A systematic review. J Med Virol, 90(1), 3-7.

Macesic N, Hall V, Mahony A, Hueston L, Ng G, Macdonell R, Hughes A, Fitt G and Grayson ML. (2016). Acute Flaccid Paralysis: The New, The Old, and The Preventable. Open Forum Infect Dis, 3(1), 1-4.

Broccolini A and Mirabella M. (2015). Hereditary inclusion-body myopathies. Biochimica et Biophysica Acta (BBA) Molecular Basis of Disease, 1852(4), 644-650.

Borawski K, Pancewicz S, Czupryna P, Zajkowska J and Moniuszko-Malinowska A. (2018). Tick paralysis. Przegl Epidemiol, 72(1), 17-24.

Balwani M, Singh P, Seth A, Debnath EM, Naik H, Doheny D, Chen B, Yasuda M and Desnick RJ. (2016). Acute intermittent porphyria in children: a case report and review of the literature. Mol Genet Metab, 119(4), 295–299.

Alqwaifly M, Bril V and Dodig D. (2019). Acute Intermittent Porphyria: A Report of 3 Cases with Neuropathy. Case Rep Neurol, 11(1), 32-36.

Sanghi V. (2014). Neurologic manifestations of diphtheria and pertussis. Handb Clin Neurol, 121(3), 1355-9.

Evoli A. (2017). Myasthenia gravis: new developments in research and treatment. Curr Opin Neurol, 30(5), 464-470.

Peragallo JH. (2017). Pediatric Myasthenia Gravis. Semin Pediatr Neurol, 24(2), 116-121.

Schoser B, Eymard B, Datt J and Mantegazza R. (2017). Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer. J Neurol, 264(9), 1854-1863.

Ivanovski T and Miralles F. (2019). Lambert-Eaton Myasthenic syndrome: early diagnosis is key. Degener Neurol Neuromuscul Dis, 13(9), 27-37.

Ambrožová H. (2019). Botulism - a rare but still present, life-threatening disease. Epidemiol Mikrobiol Imunol, 68(1), 33-38.

Fadia M, Shroff S and Simpson E. (2019). Immune-Mediated Neuropathies. Curr Treat Options Neurol, 21, 21(6), 28.

Carrillo-Marquez MA. (2016). Botulism. Pediatr Ver, 37(5), 183-192.

Palmer BF and Clegg DJ. (2019). Physiology and Pathophysiology of Potassium Homeostasis: Core Curriculum 2019. Am J Kidney Dis, S0272-6386(19), 30715-2.

Batt J, Herridge MS and Santos CC. (2019). From skeletal muscle weakness to functional outcomes following critical illness: a translational biology perspective. Thorax, 74(11), 1091-1098.

Motomura K, Yamashita H, Yamada S, Takahashi Y and Kaneko H. (2019). Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study. Rheumatol Int, 39(10), 1733-1739.

Okogbaa J and Batiste L. (2019). Dermatomyositis: An Acute Flare and Current Treatments. Clin Med Insights Case Rep, 18, 12, 1179547619855370.

Hepprich M, Lorscheider J, Peters N and Betz MJ. (2019). Hypothyroidism manifesting as multiple cranial neuropathies: a case report. J. Med. Case Rep, 13(1), 180.

Nehls V. (2018). Osteoarthropathien und Myopathien bei Schilddrüsenerkrankungen. DMW-Deutsche Medizinische Wochenschrift, 143(16), 1174-1180.

Katzberg HD and Kassardjian CD. (2016). Toxic and endocrine myopathies. CONTINUUM: Lifelong Learning in Neurology, 22(6), 1815-1828.

Willison HJ, Jacobs BC and van Doorn PA. (2016). Guillain-barre syndrome. The Lancet, 388(10045), 717-727.